PI3K/mTOR inhibitors promote G6PD autophagic degradation and exacerbate oxidative stress damage to radiosensitize small cell lung cancer
H Deng, Y Chen, L Wang, Y Zhang, Q Hang, P Li… - Cell Death & …, 2023 - nature.com
Our previous study revealed that PI3K/AKT/mTOR signaling was associated with SCLC
radioresistance. SBC2 cells were used as primary radioresistance models, while H446 cells …
radioresistance. SBC2 cells were used as primary radioresistance models, while H446 cells …
Effectiveness of CT radiomic features combined with clinical factors in predicting prognosis in patients with limited-stage small cell lung cancer
J Wu, Y Zhou, C Xu, C Yang, B Liu, L Zhao, J Song… - BMC cancer, 2024 - Springer
Background The prognosis of SCLC is poor and difficult to predict. The aim of this study was
to explore whether a model based on radiomics and clinical features could predict the …
to explore whether a model based on radiomics and clinical features could predict the …
大分割放疗联合EP 方案化疗治疗局限期小细胞肺癌的临床疗效及安全性
何宜生， 鲍亮亮， 余嘉文， 吕杨 - 肿瘤防治研究, 2023 - zlfzyj.com
大分割放疗联合EP方案化疗治疗局限期小细胞肺癌的临床疗效及安全性 Page 1 肿瘤防治研究
2023年第50卷第2期 Cancer Res Prev Treat,2023,Vol.50,No.2 ·170· doi:10.3971/j.issn.1000-8578.2023.22.0848 …
2023年第50卷第2期 Cancer Res Prev Treat,2023,Vol.50,No.2 ·170· doi:10.3971/j.issn.1000-8578.2023.22.0848 …
[HTML][HTML] Optimum cycles of induction chemotherapy in concurrent chemo-radiotherapy management of unresectable stage III non-small cell lung cancer: Results from …
MBM Yacouba, M Feng, E Thokerunga, CC Bongolo… - Medicine, 2023 - journals.lww.com
Induction chemotherapy (IC) prior to concurrent chemo-radiotherapy is the recommended
treatment for unresectable stage III non-small cell lung cancer (NSCLC). However, the …
treatment for unresectable stage III non-small cell lung cancer (NSCLC). However, the …
Clinical Efficiency and Safety of Hypofractionated Thoracic Radiotherapy Combined with EP Chemotherapy on Patients with Limited-stage Small-cell Lung Cancer
HE Yisheng, BAO Liangliang, YU Jiawen… - Cancer Research on …, 2023 - zlfzyj.com
Objective To investigate the efficacy and safety of hypofractionated thoracic radiotherapy
combined with EP chemotherapy in the treatment of limited-stage small-cell lung cancer (LS …
combined with EP chemotherapy in the treatment of limited-stage small-cell lung cancer (LS …